| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Toxicology, National Institute of Occupational Health, P. O. Box 8149 Dep, 0033 Oslo 1, Norway [L. M., D. R., A. H.], and Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 [R. A. M., W. P. B., C. C. H.]
The carcinogenicity of certain nickel compounds is well known. We have previously shown that human kidney epithelial cells were immortalized by treatment with Ni(II) and in cooperation with the v-Ha-ras oncogene transformed the cells to acquire tumorigenicity in athymic nude mice. Immunocytochemistry and sequence analysis of DNA from the nickel-immortalized cells revealed abnormal p53 expression and a T
C transition mutation in codon 238. These data are consistent with the hypothesis that Ni(II)-induced mutation in the p53 gene can be involved in the escape from senescence of kidney epithelial cells.
1 This work was supported by the Norwegian Research Council for Science and the Humanities and the Norwegian Cancer Society.
2 To whom requests for reprints should be addressed.
Received 9/ 3/91. Accepted 11/ 8/91.
This article has been cited by other articles:
![]() |
A. C. Miller, S. Mog, L. McKinney, L. Luo, J. Allen, J. Xu, and N. Page Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects Carcinogenesis, January 1, 2001; 22(1): 115 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Salnikow, W. G. An, G. Melillo, M. V. Blagosklonny, and M. Costa Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors Carcinogenesis, September 1, 1999; 20(9): 1819 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Koo, M. Gray-Goodrich, G. Kohlhagen, M. J. McWilliams, M. Jeffers, A. Vaigro-Wolff, W. G. Alvord, A. Monks, K. D. Paull, Y. Pommier, et al. The ras Oncogene-Mediated Sensitization of Human Cells to Topoisomerase II Inhibitor-Induced Apoptosis J Natl Cancer Inst, February 3, 1999; 91(3): 236 - 244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |